Thursday, April 25, 2024

Astellas Bladder Treatment Wins U.S. Approval For Sale

The Food and Drug Administration cleared the drug, mirabegron, to treat the need to frequently or involuntarily urinate, the agency said today in a statement. The drug enhances bladder storage without affecting patients’ ability to urinate like others on the market. Tokyo-based Astellas will market the treatment as Myrbetriq, the FDA said.

Are You Taking Too Many Meds?

For Alesandra Rain, it all started with sleeplessness. In 1993 she was having marital troubles and her business wasn't doing well. Anxiety kept her up at night, so her general practitioner prescribed sleeping pills.

Hundreds Of Herbal Products To Be Outlawed Across EU In Early...

The global effort to outlaw herbs, vitamins and supplements is well under way, and in just four months, hundreds of herbal products will be criminalized in the UK and across the EU. It's all part of an EU directive passed in 2004 which erects "disproportionate" barriers against herbal remedies by requiring them to be "licensed" before they can be sold.

Lies, Damn Lies And Medical Research

Mahatma Gandhi was once asked by a reporter what he thought about western civilization, and in light of the uncivilized treatment by the British government of his nonviolent actions, he immediately replied, "Western civilization? Yes, it is a good idea." Likewise, if he were asked what he thought about "scientific medicine," he would probably have replied in a similar manner.

Some Antidepressants May Bump Up Cataract Risk

Seniors who take SSRI antidepressants may be more likely to develop cataracts, says the first major study to examine this interaction. The risk appears to increase by about 15 percent, which in the United States would translate to 22,000 cataract cases attributable to antidepressant use.

Psychiatric Medications’ Effect On Brain Structure Varies

It is increasingly recognized that chronic psychotropic drug treatment may lead to structural remodeling of the brain. Indeed, clinical studies in humans present an intriguing picture: antipsychotics, used for the treatment of schizophrenia and psychosis, may contribute to cortical gray matter loss in patients, whereas lithium, used for the treatment of bipolar disorder and mania, may preserve gray matter in patients.

ANH: Another Hatchet Job From Consumer Reports

Consumer Reports (CR) claims to be a trustworthy, unbiased source of information. But where nutritional supplements are concerned, they either think that scare-mongering sells, or they have a deep bias, or both. The lead article in their September issue identifies ten supposed “hazards” of supplements—among them that “supplements are not risk-free.”

Putting A Bull’s-Eye On The Flu: Detailing Influenza’s Structure For Drug...

Beating the flu is already tough, but it has become even harder in recent years -- the influenza A virus has mutated so that two antiviral drugs don't slow it down anymore. Reporting their findings in the journal Science, researchers from Florida State and Brigham Young move closer to understanding why not, and how future treatments can defeat the nasty bug no matter how it changes.

ANH Exclusive! Natural Health Products Ultra-Safe And Drugs As Dangerous As...

A picture tells a thousand words, so they say. Today, ANH-Intl releases hard data in graphical format, from official sources, showing that food supplements are the safest substances to which we are commonly exposed – while being the target of increasingly restrictive European legislation aimed at ‘protecting consumers’.

Popular Diabetes Drugs Associated With Fractures In Type 2 Diabetic Patients,...

Postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Diabetes drug costs soaring, top $12B last year

Americans with diabetes nearly doubled their spending on drugs for the disease in just six years, with the bill last year climbing to an eye-popping $12.5 billion. Newer, more costly drugs are driving the increase, said researchers, despite a lack of strong evidence for the new drugs’ greater benefits and safety. And there are more ...

Poisoning By Prescription Drugs On The Rise

Poisoning is now the second leading cause of unintentional injury death in the U.S. While several recent high-profile Hollywood celebrity cases have brought the problem to public attention, the rates of unintentional poisoning deaths have been on the rise for more than 15 years, and in fact, unintentional poisoning has surpassed motor vehicle crashes...